A New Era in the Treatment of Chronic Kidney Disease
ProKidney is a late clinical-stage biotech company focused on the development of a pioneering cell therapy candidate that aims to transform the treatment landscape for Chronic Kidney Disease, with the potential to preserve kidney function and change patients' lives.
ProKidney is a pioneer in the treatment of Chronic Kidney Disease (CKD). While current treatments for CKD can slow the progression of kidney failure, there is no cure for CKD. At ProKidney we are at the forefront in the field of cellular therapy focused on delaying the progression to kidney failure and the need for dialysis.
- ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney DiseaseJan 10, 2023
- ProKidney to Present at the J.P. Morgan 41st Annual Healthcare ConferenceDec 22, 2022
- ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate HighlightsNov 14, 2022